Enveric Biosciences, Inc.ENVBEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Enveric Biosciences, Inc. is a clinical-stage biotechnology company developing novel therapeutics derived from cannabinoids and related molecules. Its product pipeline addresses unmet needs in mental health disorders including anxiety, depression, and treatment-resistant conditions, as well as adverse effects linked to cancer treatment. It operates mainly in North American and European biopharmaceutical markets, partnering with research institutes to advance candidates for underserved patient groups.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Hudson Bay Capital Management LP | 4.54% | 110.4K | — | 2024-02-05 |
| AdvisorShares Trust | 4.11% | 367.0K | — | 2024-11-12 |
| Mitchell | 3.10% | 290.0K | ▼ -3.10pp | 2024-11-13 |
| Armistice Capital, LLC | 0.00% | 29.4K | ▼ -9.99pp | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.